90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1

Lade...
Vorschaubild
Dateien
Zu diesem Dokument gibt es keine Dateien.
Datum
2013
Autor:innen
Lodermeyer, Veronika
Suhr, Kristina
Schrott, Nicola
Kolbe, Christian
Stürzel, Christina M.
Krnavek, Daniela
Münch, Jan
Kirchhoff, Frank
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Gold
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Retrovirology. 2013, 10(1), pp. 111-128. ISSN 1742-4690. eISSN 1742-4690. Available under: doi: 10.1186/1742-4690-10-111
Zusammenfassung

Background:
In response to viral infections, interferons induce the transcription of several hundred genes in mammalian cells. Specific antiviral functions, however, have only been attributed to a few of them. 90K/LGALS3BP has been reported to be an interferon-stimulated gene that is upregulated in individuals with cancer or HIV-1 infection.


Results:

Here, we show that 90K expression dose-dependently decreased the particle infectivity of HIV-1 progeny. The lower infectivity of released particles correlated with reduced virion incorporation of mature envelope glycoproteins gp120 and gp41. Further, proteolytic processing of the gp160 precursor and surface expression of gp120 in the producer cell were impaired in the presence of 90K expression. In contrast, expression of Gag, Nef and Vpu, and virus release were not grossly affected by 90K expression. 90K-imposed restriction occurred in the absence of direct interaction of 90K with HIV-1 Env or entrapment of Env in the ER. The cell-associated, but not the secreted species of 90K, mediated the antiviral effect. A truncated version of human 90K, solely consisting of the two intermediate domains, displayed a similar antiviral activity as the full-length wildtype 90K, indicating that the N-terminal SRCR-like domain and the C-terminal domain are dispensable for 90K’s antiviral activity. The murine homolog of 90K, CypCAP (Cyclophilin C-associated protein), neither modulated particle infectivity of HIV-1 nor lowered the virion incorporation of mature gp120, suggesting a species-specific mode of action. 90K was expressed at basal levels in TZM-bl cells and in primary macrophages, and at low levels in CD4+ T-cells and PBMCs. 90K’s susceptibility to IFN-mediated stimulation of expression was cell type-specific. siRNA-mediated knockdown of 90K in TZM-bl cells and primary macrophages enhanced the incorporation of Env glycoproteins into progeny virions, boosted the particle infectivity of released HIV-1, and accelerated HIV-1 spread. Conversely, treatment of HIV-1 infected macrophages with IFN-α induced 90K expression and lowered the particle infectivity of HIV-1.


Conclusions:

Thus, 90K constitutes a novel antiviral factor that reduces the particle infectivity of HIV-1, involving interference with the maturation and incorporation of HIV-1 Env molecules into virions.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
004 Informatik
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690LODERMEYER, Veronika, Kristina SUHR, Nicola SCHROTT, Christian KOLBE, Christina M. STÜRZEL, Daniela KRNAVEK, Jan MÜNCH, Christian DIETZ, Tanja WALDMANN, Frank KIRCHHOFF, Christine GOFFINET, 2013. 90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1. In: Retrovirology. 2013, 10(1), pp. 111-128. ISSN 1742-4690. eISSN 1742-4690. Available under: doi: 10.1186/1742-4690-10-111
BibTex
@article{Lodermeyer2013inter-27803,
  year={2013},
  doi={10.1186/1742-4690-10-111},
  title={90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1},
  number={1},
  volume={10},
  issn={1742-4690},
  journal={Retrovirology},
  pages={111--128},
  author={Lodermeyer, Veronika and Suhr, Kristina and Schrott, Nicola and Kolbe, Christian and Stürzel, Christina M. and Krnavek, Daniela and Münch, Jan and Dietz, Christian and Waldmann, Tanja and Kirchhoff, Frank and Goffinet, Christine}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/27803">
    <dc:contributor>Kirchhoff, Frank</dc:contributor>
    <dc:contributor>Münch, Jan</dc:contributor>
    <dcterms:title>90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1</dcterms:title>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/27803/2/Lodermeyer_278032.pdf"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-05-16T08:57:26Z</dcterms:available>
    <dc:contributor>Stürzel, Christina M.</dc:contributor>
    <dc:contributor>Suhr, Kristina</dc:contributor>
    <dc:creator>Dietz, Christian</dc:creator>
    <dc:contributor>Schrott, Nicola</dc:contributor>
    <dc:creator>Kolbe, Christian</dc:creator>
    <dc:creator>Stürzel, Christina M.</dc:creator>
    <dc:creator>Suhr, Kristina</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/36"/>
    <dc:creator>Krnavek, Daniela</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/27803/2/Lodermeyer_278032.pdf"/>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:creator>Schrott, Nicola</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/36"/>
    <dcterms:issued>2013</dcterms:issued>
    <dc:creator>Lodermeyer, Veronika</dc:creator>
    <dc:contributor>Lodermeyer, Veronika</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Dietz, Christian</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-05-16T08:57:26Z</dc:date>
    <dc:contributor>Waldmann, Tanja</dc:contributor>
    <dc:creator>Waldmann, Tanja</dc:creator>
    <dcterms:abstract xml:lang="eng">Background:&lt;br /&gt;In response to viral infections, interferons induce the transcription of several hundred genes in mammalian cells. Specific antiviral functions, however, have only been attributed to a few of them. 90K/LGALS3BP has been reported to be an interferon-stimulated gene that is upregulated in individuals with cancer or HIV-1 infection.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Results:&lt;br /&gt;&lt;br /&gt;Here, we show that 90K expression dose-dependently decreased the particle infectivity of HIV-1 progeny. The lower infectivity of released particles correlated with reduced virion incorporation of mature envelope glycoproteins gp120 and gp41. Further, proteolytic processing of the gp160 precursor and surface expression of gp120 in the producer cell were impaired in the presence of 90K expression. In contrast, expression of Gag, Nef and Vpu, and virus release were not grossly affected by 90K expression. 90K-imposed restriction occurred in the absence of direct interaction of 90K with HIV-1 Env or entrapment of Env in the ER. The cell-associated, but not the secreted species of 90K, mediated the antiviral effect. A truncated version of human 90K, solely consisting of the two intermediate domains, displayed a similar antiviral activity as the full-length wildtype 90K, indicating that the N-terminal SRCR-like domain and the C-terminal domain are dispensable for 90K’s antiviral activity. The murine homolog of 90K, CypCAP (Cyclophilin C-associated protein), neither modulated particle infectivity of HIV-1 nor lowered the virion incorporation of mature gp120, suggesting a species-specific mode of action. 90K was expressed at basal levels in TZM-bl cells and in primary macrophages, and at low levels in CD4+ T-cells and PBMCs. 90K’s susceptibility to IFN-mediated stimulation of expression was cell type-specific. siRNA-mediated knockdown of 90K in TZM-bl cells and primary macrophages enhanced the incorporation of Env glycoproteins into progeny virions, boosted the particle infectivity of released HIV-1, and accelerated HIV-1 spread. Conversely, treatment of HIV-1 infected macrophages with IFN-α induced 90K expression and lowered the particle infectivity of HIV-1.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Conclusions:&lt;br /&gt;&lt;br /&gt;Thus, 90K constitutes a novel antiviral factor that reduces the particle infectivity of HIV-1, involving interference with the maturation and incorporation of HIV-1 Env molecules into virions.</dcterms:abstract>
    <dc:contributor>Kolbe, Christian</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Kirchhoff, Frank</dc:creator>
    <dc:contributor>Goffinet, Christine</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Goffinet, Christine</dc:creator>
    <dcterms:bibliographicCitation>Retrovirology ; 10 (2013), 1. - S. 111-128</dcterms:bibliographicCitation>
    <dc:rights>terms-of-use</dc:rights>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/27803"/>
    <dc:language>eng</dc:language>
    <dc:creator>Münch, Jan</dc:creator>
    <dc:contributor>Krnavek, Daniela</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen